
Metastatic Cancer Drugs Global Market Report 2023 Including: 1) By Drug Class: HER2 Inhibitors; Immune Checkpoints Inhibitors; PARP Inhibitors; Kinase Inhibitors 2) By Cancer: Breast Cancer; Lung Cancer; Liver Cancer; Hematological Cancer; Brain Cancer; P
Description
Metastatic Cancer Drugs Global Market Report 2023
Including: 1) By Drug Class: HER2 Inhibitors; Immune Checkpoints Inhibitors; PARP Inhibitors; Kinase Inhibitors2) By Cancer: Breast Cancer; Lung Cancer; Liver Cancer; Hematological Cancer; Brain Cancer; Prostate Cancer; Pancreatic Cancer3) By Treatment: Chemotherapy; Immunotherapy; Hormonal Therapy; Surgery4) By Route Of Administration: Intravenous; Intramuscular; Oral5) By End-Users: Hospitals; Specialty ClinicssCovering: Pfizer Inc.; Johnson and Johnson Services Inc.; F. Hoffmann-La Roche AG; Merck & Co. Inc.; AbbVie Inc.
Metastatic Cancer Drugs Global Market Report 2023 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on metastatic cancer drugs market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
- Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
- Assess the Russia – Ukraine war’s impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
- Measure the impact of high global inflation on market growth.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for metastatic cancer drugs? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The metastatic cancer drugs market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
Scope
Markets Covered:1) By Drug Class: HER2 Inhibitors; Immune Checkpoints Inhibitors; PARP Inhibitors; Kinase Inhibitors; Other Drug Class
2) By Cancer: Breast Cancer; Lung Cancer; Liver Cancer; Hematological Cancer; Brain Cancer; Prostate Cancer; Pancreatic Cancer; Other Cancers
3) By Treatment: Chemotherapy; Immunotherapy; Hormonal Therapy; Surgery; Other Treatments
4) By Route Of Administration: Intravenous; Intramuscular; Oral; Other Routes Of Administration
5) By End-Users: Hospitals; Specialty Clinics; Other End-Users
Companies Mentioned: Pfizer Inc.; Johnson and Johnson Services Inc.; F. Hoffmann-La Roche AG; Merck & Co. Inc.; AbbVie Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.
Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.
Table of Contents
175 Pages
- 1. Executive Summary
- 2. Metastatic Cancer Drugs Market Characteristics
- 3. Metastatic Cancer Drugs Market Trends And Strategies
- 4. Metastatic Cancer Drugs Market - Macro Economic Scenario
- 4.1. Impact Of High Inflation On Online Therapy Services Market
- 4.2. Ukraine-Russia War Impact On Online Therapy Services Market
- 4.3. COVID-19 Impact On Online Therapy Services Market
- 5.1. Global Metastatic Cancer Drugs Historic Market Size and Growth, 2017 - 2022, Value ($ Billion)
- 5.2. Global Metastatic Cancer Drugs Forecast Market Size and Growth, 2022 - 2027, 2032F, Value ($ Billion)
- 5.3. Global Metastatic Cancer Drugs Market Drivers and Restraints
- 5.3.1. Drivers Of The Market
- 5.3.2. Restraints Of The Market
- 6. Metastatic Cancer Drugs Market Segmentation
- 6.1. Global Metastatic Cancer Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- HER2 Inhibitors
- Immune Checkpoints Inhibitors
- PARP Inhibitors
- Kinase Inhibitors
- Other Drug Class
- 6.2. Global Metastatic Cancer Drugs Market, Segmentation By Cancer, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Breast Cancer
- Lung Cancer
- Liver Cancer
- Hematological Cancer
- Brain Cancer
- Prostate Cancer
- Pancreatic Cancer
- Other Cancers
- 6.3. Global Metastatic Cancer Drugs Market, Segmentation By Treatment, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Chemotherapy
- Immunotherapy
- Hormonal Therapy
- Surgery
- Other Treatments
- 6.4. Global Metastatic Cancer Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Intravenous
- Intramuscular
- Oral
- Other Routes Of Administration
- 6.5. Global Metastatic Cancer Drugs Market, Segmentation By End-Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Hospitals
- Specialty Clinics
- Other End-Users
- 7. Metastatic Cancer Drugs Market Regional And Country Analysis
- 7.1. Global Metastatic Cancer Drugs Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 7.2. Global Metastatic Cancer Drugs Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 8. Asia-Pacific Metastatic Cancer Drugs Market
- 8.1. Asia-Pacific Metastatic Cancer Drugs Market Overview
- Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Metastatic Cancer Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 8.3. Asia-Pacific Metastatic Cancer Drugs Market, Segmentation By Cancer, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 8.4. Asia-Pacific Metastatic Cancer Drugs Market, Segmentation By End-Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 9. China Metastatic Cancer Drugs Market
- 9.1. China Metastatic Cancer Drugs Market Overview
- 9.2. China Metastatic Cancer Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion
- 9.3. China Metastatic Cancer Drugs Market, Segmentation By Cancer, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion
- 9.4. China Metastatic Cancer Drugs Market, Segmentation By End-Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion
- 10. India Metastatic Cancer Drugs Market
- 10.1. India Metastatic Cancer Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 10.2. India Metastatic Cancer Drugs Market, Segmentation By Cancer, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 10.3. India Metastatic Cancer Drugs Market, Segmentation By End-Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 11. Japan Metastatic Cancer Drugs Market
- 11.1. Japan Metastatic Cancer Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 11.2. Japan Metastatic Cancer Drugs Market, Segmentation By Cancer, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 11.3. Japan Metastatic Cancer Drugs Market, Segmentation By End-Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 12. Australia Metastatic Cancer Drugs Market
- 12.1. Australia Metastatic Cancer Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 12.2. Australia Metastatic Cancer Drugs Market, Segmentation By Cancer, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 12.3. Australia Metastatic Cancer Drugs Market, Segmentation By End-Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 13. Indonesia Metastatic Cancer Drugs Market
- 13.1. Indonesia Metastatic Cancer Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 13.2. Indonesia Metastatic Cancer Drugs Market, Segmentation By Cancer, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 13.3. Indonesia Metastatic Cancer Drugs Market, Segmentation By End-Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 14. South Korea Metastatic Cancer Drugs Market
- 14.1. South Korea Metastatic Cancer Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 14.2. South Korea Metastatic Cancer Drugs Market, Segmentation By Cancer, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 14.3. South Korea Metastatic Cancer Drugs Market, Segmentation By End-Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 15. Western Europe Metastatic Cancer Drugs Market
- 15.1. Western Europe Metastatic Cancer Drugs Market Overview
- 15.2. Western Europe Metastatic Cancer Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 15.3. Western Europe Metastatic Cancer Drugs Market, Segmentation By Cancer, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 15.4. Western Europe Metastatic Cancer Drugs Market, Segmentation By End-Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 16. UK Metastatic Cancer Drugs Market
- 16.1. UK Metastatic Cancer Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 16.2. UK Metastatic Cancer Drugs Market, Segmentation By Cancer, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 16.3. UK Metastatic Cancer Drugs Market, Segmentation By End-Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 17. Germany Metastatic Cancer Drugs Market
- 17.1. Germany Metastatic Cancer Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 17.2. Germany Metastatic Cancer Drugs Market, Segmentation By Cancer, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 17.3. Germany Metastatic Cancer Drugs Market, Segmentation By End-Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 18. France Metastatic Cancer Drugs Market
- 18.1. France Metastatic Cancer Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 18.2. France Metastatic Cancer Drugs Market, Segmentation By Cancer, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 18.3. France Metastatic Cancer Drugs Market, Segmentation By End-Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 19. Italy Metastatic Cancer Drugs Market
- 19.1. Italy Metastatic Cancer Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 19.2. Italy Metastatic Cancer Drugs Market, Segmentation By Cancer, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 19.3. Italy Metastatic Cancer Drugs Market, Segmentation By End-Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 20. Spain Metastatic Cancer Drugs Market
- 20.1. Spain Metastatic Cancer Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 20.2. Spain Metastatic Cancer Drugs Market, Segmentation By Cancer, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 20.3. Spain Metastatic Cancer Drugs Market, Segmentation By End-Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 21. Eastern Europe Metastatic Cancer Drugs Market
- 21.1. Eastern Europe Metastatic Cancer Drugs Market Overview
- 21.2. Eastern Europe Metastatic Cancer Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 21.3. Eastern Europe Metastatic Cancer Drugs Market, Segmentation By Cancer, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 21.4. Eastern Europe Metastatic Cancer Drugs Market, Segmentation By End-Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 22. Russia Metastatic Cancer Drugs Market
- 22.1. Russia Metastatic Cancer Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 22.2. Russia Metastatic Cancer Drugs Market, Segmentation By Cancer, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 22.3. Russia Metastatic Cancer Drugs Market, Segmentation By End-Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 23. North America Metastatic Cancer Drugs Market
- 23.1. North America Metastatic Cancer Drugs Market Overview
- 23.2. North America Metastatic Cancer Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 23.3. North America Metastatic Cancer Drugs Market, Segmentation By Cancer, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 23.4. North America Metastatic Cancer Drugs Market, Segmentation By End-Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 24. USA Metastatic Cancer Drugs Market
- 24.1. USA Metastatic Cancer Drugs Market Overview
- 24.2. USA Metastatic Cancer Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 24.3. USA Metastatic Cancer Drugs Market, Segmentation By Cancer, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 24.4. USA Metastatic Cancer Drugs Market, Segmentation By End-Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 25. Canada Metastatic Cancer Drugs Market
- 25.1. Canada Metastatic Cancer Drugs Market Overview
- 25.2. Canada Metastatic Cancer Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 25.3. Canada Metastatic Cancer Drugs Market, Segmentation By Cancer, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 25.4. Canada Metastatic Cancer Drugs Market, Segmentation By End-Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 26. South America Metastatic Cancer Drugs Market
- 26.1. South America Metastatic Cancer Drugs Market Overview
- 26.2. South America Metastatic Cancer Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 26.3. South America Metastatic Cancer Drugs Market, Segmentation By Cancer, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 26.4. South America Metastatic Cancer Drugs Market, Segmentation By End-Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 27. Brazil Metastatic Cancer Drugs Market
- 27.1. Brazil Metastatic Cancer Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 27.2. Brazil Metastatic Cancer Drugs Market, Segmentation By Cancer, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 27.3. Brazil Metastatic Cancer Drugs Market, Segmentation By End-Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 28. Middle East Metastatic Cancer Drugs Market
- 28.1. Middle East Metastatic Cancer Drugs Market Overview
- 28.2. Middle East Metastatic Cancer Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 28.3. Middle East Metastatic Cancer Drugs Market, Segmentation By Cancer, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 28.4. Middle East Metastatic Cancer Drugs Market, Segmentation By End-Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 29. Africa Metastatic Cancer Drugs Market
- 29.1. Africa Metastatic Cancer Drugs Market Overview
- 29.2. Africa Metastatic Cancer Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 29.3. Africa Metastatic Cancer Drugs Market, Segmentation By Cancer, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 29.4. Africa Metastatic Cancer Drugs Market, Segmentation By End-Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 30. Metastatic Cancer Drugs Market Competitive Landscape And Company Profiles
- 30.1. Metastatic Cancer Drugs Market Competitive Landscape
- 30.2. Metastatic Cancer Drugs Market Company Profiles
- 30.2.1. Pfizer Inc.
- 30.2.1.1. Overview
- 30.2.1.2. Products and Services
- 30.2.1.3. Strategy
- 30.2.1.4. Financial Performance
- 30.2.2. Johnson and Johnson Services Inc.
- 30.2.2.1. Overview
- 30.2.2.2. Products and Services
- 30.2.2.3. Strategy
- 30.2.2.4. Financial Performance
- 30.2.3. F. Hoffmann-La Roche AG
- 30.2.3.1. Overview
- 30.2.3.2. Products and Services
- 30.2.3.3. Strategy
- 30.2.3.4. Financial Performance
- 30.2.4. Merck & Co. Inc.
- 30.2.4.1. Overview
- 30.2.4.2. Products and Services
- 30.2.4.3. Strategy
- 30.2.4.4. Financial Performance
- 30.2.5. AbbVie Inc.
- 30.2.5.1. Overview
- 30.2.5.2. Products and Services
- 30.2.5.3. Strategy
- 30.2.5.4. Financial Performance
- 31. Metastatic Cancer Drugs Market Other Major And Innovative Companies
- 31.1. Bayer AG
- 31.2. AstraZeneca plc
- 31.3. Novartis AG
- 31.4. Sanofi S.A.
- 31.5. Bristol-Myers Squibb Company
- 31.6. Takeda Pharmaceutical Company Limited
- 31.7. Eli Lilly and Company
- 31.8. Gilead Sciences Inc.
- 31.9. Amgen Inc.
- 31.10. Astellas Pharma Inc.
- 31.11. Eisai Co. Ltd.
- 31.12. Sun Pharmaceutical Industries Ltd.
- 31.13. Incyte Corporation
- 31.14. Ipsen SA
- 31.15. Seagen Inc.
- 32. Global Metastatic Cancer Drugs Market Competitive Benchmarking
- 33. Global Metastatic Cancer Drugs Market Competitive Dashboard
- 34. Key Mergers And Acquisitions In The Metastatic Cancer Drugs Market
- 35. Metastatic Cancer Drugs Market Future Outlook and Potential Analysis
- 35.1 Metastatic Cancer Drugs Market In 2027 - Countries Offering Most New Opportunities
- 35.2 Metastatic Cancer Drugs Market In 2027 - Segments Offering Most New Opportunities
- 35.3 Metastatic Cancer Drugs Market In 2027 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
- 36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.